Aspire Biopharma Holdings, INC. (ASBPW) — 10-Q/A Filings
All 10-Q/A filings from Aspire Biopharma Holdings, INC.. Browse 3 Amended Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q/A Filings (3)
-
Aspire Biopharma's Net Loss Explodes to $19.8M Amidst Reverse Acquisition
— Nov 14, 2025 Risk: high
Aspire Biopharma Holdings, Inc. (ASBPW) reported a significant net loss of $19,773,114 for the nine months ended September 30, 2025, a substantial increase from -
Aspire Biopharma Restates Q1, Reveals $1M Liability Error
— Aug 13, 2025 Risk: high
Aspire Biopharma Holdings, Inc. (ASBPW) filed a 10-Q/A to restate its Q1 2025 financial statements, correcting an understatement of liabilities and an overstate -
PowerUp Acquisition Corp. Files 10-Q/A for Q1 2024
— Oct 24, 2024 Risk: low
PowerUp Acquisition Corp. filed an amendment (10-Q/A) on October 24, 2024, for the quarterly period ended March 31, 2024. The company, previously named PowsedrU
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX